Digital therapy app doubles depression improvement in primary care patients

Patients with depression who received the Moodivate app saw clinically meaningful reductions in their symptoms that were twice those achieved with standard-of-care therapy in a clinical trial conducted at 22 primary care practices in Charleston, South Carolina. App users were also 3 times more likely to achieve a clinically meaningful improvement in their depression and 2.3 times more likely to attain depression remission. Moodivate (available on both iOS and Android) is a digital version of behavioral activation, a type of behavioral therapy that has proved effective against depression.